There is preclinical data that suggests curcumin is a normal tissue radioprotector and a tumor sensitizer. That is a difficult combination to achieve and I am skeptical. There is also preclinical data that it works on a number of patho-physiologic pathways, some common and other specific to particu...

I'll present a bit of a counter argument. I've had patients mention curcumin, and they've all been prostate patients. There was a study a few years ago that curcumin helped reduce urinary side effects during XRT. It made its way 'round the 'net, and prostate CA patients do a lot of internet research...

In integrative Oncology, its important to keep in mind the purpose of any intervention we are considering-- preventive (of which there can be primary, secondary and tertiary prevention considerations), supportive care and antineoplastic care. Data requirements generally flow in line with the categor...